Refractory and relapsed paediatric ACC in the MET studies – A challenging situation necessitating novel diagnostic and therapeutic concepts
-
Published:2023
Issue:
Volume:1
Page:100015
-
ISSN:2772-610X
-
Container-title:EJC Paediatric Oncology
-
language:en
-
Short-container-title:EJC Paediatric Oncology
Author:
Kuhlen MichaelaORCID,
Kunstreich Marina,
Lessel Lienhard,
Wudy Stefan A.,
Holterhus Paul-Martin,
Vokuhl Christian,
Juettner Eva,
Roecken Christoph,
Seitz Guido,
Slavetinsky ChristophORCID,
Fuchs Jörg,
Schewe Denis M.,
Claus Rainer,
Johann Pascal D.,
Frühwald Michael C.,
Vorwerk Peter,
Redlich Antje
Reference35 articles.
1. The International Pediatric Adrenocortical Tumor Registry initiative: contributions to clinical, biological, and treatment advances in pediatric adrenocortical tumors;Ribeiro;Mol. Cell. Endocrinol.,2012
2. Outcome and prognostic factors in high-risk childhood adrenocortical carcinomas: a report from the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT);Cecchetto;Pediatr. Blood Cancer,2017
3. Treatment of pediatric adrenocortical carcinoma with surgery, retroperitoneal lymph node dissection, and chemotherapy: the Children's Oncology Group ARAR0332 protocol;Rodriguez-Galindo;J. Clin. Oncol.,2021
4. Biology, clinical characteristics, and management of adrenocortical tumors in children;Rodriguez-Galindo;Pediatr. Blood Cancer,2005
5. Outcome of adrenocortical tumors in children;Hanna;J. Pediatr. Surg.,2008
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献